Natural health pharma manufacturer scaling via acquisition and new product launches
EA Pharma manufactures micronutrition and complementary health products across three business areas: health, sport, and wellness. The hiring surge (17 roles posted in the last 30 days, accelerating velocity) is concentrated in finance and marketing rather than manufacturing, while active projects focus on post-acquisition integration, new product launches, and regulatory validation — indicating the company is in active growth mode through M&A and market expansion. Pain-point data reveals operational strain: P&L reliability, export documentation, and sales performance are top challenges.
Notable leadership hires: Regional Director
EA Pharma is a privately held pharmaceutical manufacturer based in Mougins, France, specializing in micronutrition, oligotherapy, and complementary nutrition products sold across health, sport, and wellness segments. The company develops, manufactures, and distributes pharmaceutical and dietary supplements with stated commitments to innovation, quality, and transparency. With 51–200 employees, the operation spans manufacturing, regulatory, finance, and commercial functions. Current activity includes post-acquisition integration, new product launches, and regulatory validations, supported by tools like SAP, Power BI, and Adobe for planning and execution.
Excel, Power Query, SAP, Adobe, Canva, Zendesk, AWS, Microsoft Office, Power BI, and iPad. Stack leans toward finance/reporting (Power Query, Power BI) and marketing (Adobe, Canva).
Headquartered in Mougins, France. Currently hiring only in France, but pain-point data indicates expansion into new international markets is a priority.
Other companies in the same industry, closest in size